Point-of-care PCR testing for STIs in the ED reduced length of stay and improved antibiotic stewardship compared with central laboratory testing.

3EO becomes the first point-of-care molecular technology to be retail priced below $15 per test. 3EO adds a breakthrough business model enabling more physician practices to upgrade technology from ...

Recent advances in portable and automated molecular diagnostic systems will address the previously unmet need for decentralized, point-of-care nucleic acid testing. Rapid, accurate diagnostic systems ...

Polymerase chain reaction (PCR) tests are one of the most popular diagnostic tools for the detection and diagnosis of viral diseases, such as coronavirus (COVID-19), due to their ability to rapidly ...

EVANSTON, Ill.--(BUSINESS WIRE)--Minute Molecular Diagnostics today announced that the U.S. Food and Drug Administration (FDA) granted an Emergency Use Authorization (EUA) for its rapid DASH ...

Binx Health is a health technology company aiming to speed up the time between diagnosis and treatment of sexually transmitted infections with a point-of-care diagnostic solution. The company ...

The point-of-care (POC) molecular diagnostics market is steadily expanding, with a compound annual growth rate (CAGR) of approximately 6%. This growth is fueled by a growing need for fast, ...

Rochester, Minn.-based Mayo Clinic has entered into a know-how license agreement and stock purchase agreement with tech company Genomadix. As part of the agreement, Mayo Clinic will help the company ...

Looking back at the history of tuberculosis (TB) control, one small yet revolutionary change stands out — the development of point-of-care molecular diagnostics. Traditionally, TB diagnosis involved ...

Jorge Nieva, MD, highlights the critical role of molecular testing in non–small cell lung cancer (NSCLC) care, while addressing barriers such as limited tissue samples, delayed turnaround times, and ...